Market cap
₹20,709 Cr
Revenue (TTM)
₹2,520 Cr
P/E Ratio
28.7
P/B Ratio
4.9
Div. Yield
1.7 %
Quality Score
10/10
Growth Score
7/10
Valuation Score
5/10
Momentum Score
2/10
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
₹722 Cr
-
ROE
17.2 %
-
ROCE
23.4 %
-
Industry P/E
--
-
EV/EBITDA
16.1
-
Debt to Equity
0
-
Book Value
₹918.7
-
EPS
₹157.9
-
Face value
10
-
Shares outstanding
45,747,732
10 Years Aggregate
CFO
₹4,415.86 Cr
EBITDA
₹6,626.23 Cr
Net Profit
₹5,410.49 Cr
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Pfizer
| -9.1 | 1.7 | -5.2 | -22.3 | 6.0 | -4.5 | 8.8 |
|
BSE Healthcare
| 13.3 | 4.9 | 18.1 | 9.6 | 23.8 | 13.6 | 11.9 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
Pfizer
| -6.0 | 23.8 | -3.7 | -12.3 | -4.2 | 20.7 | 47.1 |
|
BSE Small Cap
| -6.6 | 29.0 | 47.5 | -1.8 | 62.8 | 32.1 | -6.8 |
|
BSE Healthcare
| -3.3 | 43.1 | 37.0 | -12.1 | 20.9 | 61.4 | -3.5 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Pfizer
|
4,532.1 | 20,708.6 | 2,519.7 | 722.4 | 33.6 | 17.2 | 28.7 | 4.9 |
| 8,141.0 | 20,375.4 | 2,275.6 | 187.5 | 10.3 | 22.9 | 108.7 | 23.3 | |
| 2,528.4 | 19,209.7 | 2,187.2 | 649.7 | 31.5 | 19 | 30 | 5.4 | |
| 1,979.4 | 12,079.7 | 1,403.2 | 185.1 | -- | 27.4 | 65.3 | 16.2 | |
| 1,416.0 | 19,593.6 | 3,129.4 | 647.4 | 26.9 | 18.1 | 31.6 | 5.0 | |
| 2,435.8 | 39,081.6 | 4,147.8 | 709.5 | 22.3 | 19.1 | 55.1 | 9.4 | |
| 6,262.5 | 10,405.6 | 1,408.0 | 326.9 | 30.8 | 57.1 | 31.8 | 19.8 | |
| 3,381.6 | 7,782.6 | 1,773.8 | 309.8 | 24.0 | 43.1 | 25.1 | 10.0 | |
| 595.4 | 11,632.2 | 1,538.1 | 226.2 | 20.4 | 9 | 47.8 | 4.5 | |
| 1,080.8 | 9,951.0 | 4,858.7 | 574.1 | 14.9 | 19.7 | 17.9 | 3.2 |
Shareholding Pattern
View DetailsNews & Analysis
All News3 min read•By Markets Desk
3 min read•By Research Desk
2 min read•By Research Desk
Diversified Equity Funds: Not Dead Yet
4 min read•By Research Desk
About Pfizer
Pfizer Limited engages in manufacturing, marketing, trading, and distribution of pharmaceutical products in India and internationally. It offers its products in various therapeutic areas, including neuro/CNS, hormones, cardiovascular, haemophilia,... anti-infectives, gynecology, pain/analgesics, orthopedic, oncology, urology, anti-parasitic, gastrointestinal, vaccines, and respiratory, as well as vitamins, minerals, and nutrients. The company also offers anti-infectives services to hospitals and nursing homes. It sells its products through a network of independent distributors. Pfizer Limited was incorporated in 1950 and is based in Mumbai, India. Read more
-
Incorporated
1950
-
Chairman
Pradip Shah
-
Managing Director
Meenakshi Nevatia
-
Group
Pfizer - MNC
-
Headquarters
Mumbai, Maharashtra
-
Website
Quarterly Updates
Annual Reports
Announcements
View AnnouncementsShareholder''s Meeting - AGM Notice
06-Jul-2026Intimation Of Date Of Annual General Meeting
12-May-2026No News & Announcements are available.
FAQs for Pfizer
What is the current share price of Pfizer Ltd Today?
The share price of Pfizer Ltd is ₹4,532.10 (NSE) and ₹4,526.70 (BSE) as of 08-Jul-2026 IST. Pfizer Ltd has given a return of 6.05% in the last 3 years.
What is the current PB & PE ratio of Pfizer Ltd?
The P/E ratio of Pfizer Ltd is 28.67 times as on 08-Jul-2026.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2026
|
29.89
|
5.14
|
|
2025
|
23.86
|
4.34
|
|
2024
|
34.80
|
5.34
|
|
2023
|
25.40
|
4.94
|
|
2022
|
32.50
|
6.95
|
What is the 52 Week High and Low of Pfizer Ltd?
The 52-week high and low of Pfizer Ltd are Rs 5,896.00 and Rs 4,360.10 as of 09-Jul-2026.
What is the market cap of Pfizer Ltd?
Pfizer Ltd has a market capitalisation of ₹ 20,709 Cr as on 08-Jul-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Pfizer Ltd?
Before investing in Pfizer Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
